Turning the Tide: How Malawi Stopped Mpox in Its Tracks

When Mpox first appeared in Malawi in April 2025, fear rippled through communities. The disease, known for its painful symptoms and potential complications, threatened to disrupt lives and strain an already burdened health system. By mid-year, cases were climbing, and the outbreak had spread to 12 districts, including Lilongwe, the country’s bustling capital. Health workers faced the daunting task of containing a virus that moves silently through close contact, often in crowded urban settings.

But Malawi fought back. In October 2025, the Ministry of Health launched a bold, reactive vaccination campaign targeting those most at risk including health workers, case contacts, and key populations in high-transmission areas. The goal was simple yet urgent: stop Mpox before it spiraled out of control. What followed was a story of resilience, innovation, and community solidarity.

Mobile outreach teams became the heartbeat of the campaign. Traveling through busy markets, urban hotspots, and remote villages, these teams brought vaccines directly to the people who needed them most. “We couldn’t wait for people to come to us,” said one district health officer in Salima. “We had to go where the risk was highest.” 

Community members welcomed the Mpox vaccination campaign with open arms. Shakina, who had received her Mpox vaccine dose in Ntcheu, encouraged others to get vaccinated without hesitation:

“This vaccine protects us, so let us all get vaccinated to safeguard our families and communities.”

Alongside fixed health facilities and temporary posts, this approach ensured no one was left behind. In just weeks, 33,605 doses were administered (100% coverage), every single one accounted for, with zero wastage. “Managing the cold chain in the field was not easy especially during moonlight sessions,” recalled a vaccination team member, “but we knew every vial mattered. We couldn’t afford to lose a single dose.”

The mpox vaccination drive in Blantyre Malawi
Ovixlexla Kamenyagwaza-Bunya
The Secretary of Health Dr Dan Namarika and WHO Representative Dr Neema Rusibamayila Kimambo engaging students on HPV vaccination in Area 49, Lilongwe District
Ovixlexla Kamenyagwaza-Bunya
The impact was almost immediate. Before vaccination, Malawi had recorded 147 confirmed Mpox cases and one death. After the campaign began, new infections plummeted by nearly 90%. By December, only three active cases remained, and all 1,412 contacts had completed follow-up. For communities that once feared the worst, this was a turning point.
Maxson Kashoti from Chirimba says prevention is better than cure
Ovixlexla Kamenyagwaza-Bunya
Health workers prioritized all hotspots and ensured no one was left behind
Ovixlexla Kamenyagwaza-Bunya
Beyond the numbers, this success reflects Malawi’s growing capacity to respond to health emergencies. Digital tools enabled real-time tracking, while strong local partnerships drove trust and uptake. “Seeing the data update live gave us confidence,” said a national level vaccine preventable disease surveillance officer. “We could make decisions on the spot and keep the campaign moving.”

The campaign didn’t just stop Mpox, it strengthened the health system and proved that with planning, data, and community engagement, even the toughest outbreaks can be contained. As Malawi looks ahead, the lessons are clear: rapid action saves lives, and resilience is built through collaboration. This Mpox response is more than a public health achievement, it’s a story of people coming together to protect each other, ensuring that hope triumphs over fear.
Engagement was key for vital for vaccine acceptance and decision making
Ovixlexla Kamenyagwaza-Bunya
Ovixlexla Kamenyagwaza-Bunya
Proudly vaccinated
For Additional Information or to Request Interviews, Please contact:
Ovixlexla Kamenyagwaza-Bunya

bunyao [at] who.int (bunyao[at]who[dot]int)

+265 999 930 280